Chemoprevention of colon cancer by Korean food plant components

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 523-524, Issue , 2003, Pages 99-107

  Kim, Dae Joong ^a   Shin, Dong Hwan ^b   Ahn, Byeongwoo ^b   Kang, Jin Seok ^b   Nam, Ki Taek ^b   Park, Cheol Beom ^a   Kim, Cheul Kyu ^b   Hong, Jin Tae ^a   Kim, Yun Bae ^a   Yun, Young Won ^a   Jang, Dong Deuk ^b   Yang, Ki Hwa ^b  

^a Chungbuk National University   (South Korea)

^b Korea Food and Drug Administration   (South Korea)

Author keywords

Adenomatous polyposis coli (APC) gene; Azoxymethane (AOM); Chemoprevention; Colon cancer; Familial adenomatous polyposis (FAP); Inducible cyclooxygenase (COX 2); Inducible nitric oxide synthase (iNOS NOS 2); Multiple intestinal neoplasia (Min)

Indexed keywords

3 INDOLEMETHANOL; AZOXYMETHANE; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ANIMAL TISSUE; BREAST; CANCER CHEMOTHERAPY; CANCER PREVENTION; CARCINOGENESIS; COLON CARCINOMA; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; HUMAN; INCIDENCE; KOREA; LIVER; MALE; MEDICINAL PLANT; MOUSE; NONHUMAN; PRIORITY JOURNAL; WILD TYPE;

ANIMALIA; BRASSICA OLERACEA VAR. BOTRYTIS; BRASSICA OLERACEA VAR. CAPITATA; BRASSICA OLERACEA VAR. GEMMIFERA; BRASSICACEAE;

EID: 19244378298     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(02)00325-1     Document Type: Conference Paper

References (50)

1. Sporn M.B. Approaches to prevention of epithelial cancer during the preneoplastic period. Cancer Res. 36:1976;2699-2702.
2. Greenwald P., Kelloff G.J., Burch-Whitman C., Kramer B.S. Chemoprevention. CA Cancer J. Clin. 45:1995;31-49.
3. Greenwald P., Kelloff G.J., Boone C.W., McDonald S.S. Genetic and cellular changes in colorectal cancer: proposed targets of chemopreventive agents. Cancer Epidemiol. Biomarkers Prev. 4:1995;691-702.
4. Landis S.H., Murray T., Bolden S., Wingo P.A. Cancer statistics. CA Cancer J. Clin. 48:1998;6-27.
5. Vogelstein B., Fearon E.R., Mamilton S.R., Kern S.E., Preisinger A.C., Leppert M., Nakamura Y., White R., Smith A.M.M., Bos J.L. Genetic alterations during colorectal tumor development. N. Engl. J. Med. 319:1988;525-532.
6. Fearon E.R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 61:1990;759-767.
7. Fearon E.R., Jones P.A. Progression toward a molecular description of colorectal cancer development. FASEB J. 6:1992;2789-2790.
8. Kinzler K.W., Nilbert M.C., Su L.K., Vogelstein B., Bryan T.M., Levy D.B., Smith K.J., Preisinger A.C., Hedge P., McKechnie D., Finniear R., Markham A., Groffen J., Boguski M.S., Altscul S.F., Horri A., Ando H., Miyoshi Y., Miki Y., Nishino I., Nakamura Y. Identification of FAP locus genes from chromosome 5q21. Science. 253:1991;661-665.
9. Kinzler K.W., Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 87:1996;159-170.
10. Paulsen J.E. Modulation by dietary factors in murine FAP models. Toxicol. Lett. 112-113:2000;403-409.
11. Giardiello F.M., Offerhaus G.J.A., DuBois R.N. The role of non-steroidal anti-inflammatory drugs in colorectal cancer prevention. Eur. J. Cancer. 31A:1995;1071-1076.
12. Rao C.V., Rivenson A., Simi B., Zang E., Kelloff G., Steele V., Reddy B.S. Chemoprevention of colon carcinogenesis by sulindac, a non-steroidalal anti-inflammatory agent. Cancer Res. 55:1995;1464-1472.
13. Boolbol S.K., Dannenberg A.J., Chadburn A., Martucci C., Guo X.J., Ramonetti J.T., Abreu-Goris M., Newmark H.L., Lipkin M.L., DeCosse J.J., Bertagnolli M.M. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res. 56:1996;2556-2560.
14. Patrignani P. Non-steroidalal anti-inflammatory drugs, COX-2 and colorectal cancer. Toxicol. Lett. 112-113:2000;493-498.
15. Eberhart C.E., Coffet R.J., Radhika A., Giardello F.M., Ferrenbach S., DuBois R.N. Upregulation of cyclooxygenase-2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology. 107:1994;1183-1188.
16. Kargman S., O'Neill G., Vickers P., Evans J., Mancini J., Jothy S. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res. 55:1995;2556-2559.
17. Sano H., Kawahito Y., Wilder R.L., Hashiramoto A., Mukai S., Asai K., Kimura S., Kato H., Kondo M., Hla T. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res. 55:1995;3785-3789.
18. DuBois R.N., Radhika A., Reddy B.S., Entingh A.J. Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology. 110:1996;1259-1262.
19. Shao J., Sheng H., Aramandla R., Pereira M.A., Lubet R.A., Hawk E., Grogan L., Kirsch I.R., Washington M.K., Beauchamp R.D., DuBois R.N. Coordinate regulation of cyclooxygenase-2 and TGF-β1 in replication error-positive colon cancer and azoxymethane-induced rat colon tumors. Carcinogenesis. 20:1999;185-191.
20. Williams C.S., Luongo C., Radhika A., Zhang T., Lamps L.W., Nanney L.B., Beauchamp R.D., DuBois R.N. Elevated cyclooxygenase-2 levels in Min mouse adenomas. Gastroenterology. 111:1996;1134-1140.
21. Ristimaki A., Honkanen N., Jankala H., Sipponen P., Harkonen M. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res. 57:1997;1276-1280.
22. Mestre J.R., Subbaramaiah K., Sacks P.G., Schantz S.P., Tanabe T., Inoue H., Dannenberg A.J. Retinoids suppress epidermal growth factor-induced transcription of cyclooxygenase-2 in human oral squamous carcinoma cells. Cancer Res. 15:1997;2890-2895.
23. Sato T., Nakajima H., Mori Y. Enhancement of prostaglandin E2 production by epidermal growth factor requires the coordinate activation of cytosolic phospholipase A2 and cyclooxygenase-2 in human squamous carcinoma A431 cells. Prostaglandins. 53:1997;355-369.
24. Wolff H., Saukkonen K., Anttila S., Karjalainen A., Vanio H., Ristimaki A. Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res. 58:1998;4997-5001.
25. Koga H., Sakisaka S., Ohishi M., Kawaguchi T., Taniguchi E., Sasatomi K., Harada M., Kusaba T., Tanaka M., Kimura R., Nakashima Y., Nakashima O., Kojiro M., Kurohiji T., Sata M. Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor differentiation. Hepatology. 29:1999;688-696.
26. Δ716 knockout mice by inhibition of cyclooxygenase-2 (COX-2). Cell. 87:1996;803-809.
27. DuBois R.N., Abramson S.B., Crofford L., Gupta R.A., Simon L.S., Van De Putte L.B.A., Lipsky P.E. Cyclooxygenase in biology and disease. FASEB J. 12:1998;1063-1073.
28. Giardiello F.M., Offerhaus G.J., DuBois R.N. The role of non-steroidalal anti-inflammatory drugs in colorectal cancer prevention. Eur. J. Cancer. 31A:1995;1071-1076.
29. DuBois R.N., Giardiello F.M., Smalley W.E. Non-steroidalal anti-inflammatory drugs, eicosanoids, and colorectal cancer prevention. Gastroenterol. Clin. North Am. 25:1996;773-791.
30. Krishnan K., Brenner D.E. Chemoprevention of colorectal cancer. Gastroenterol. Clin. North Am. 25:1996;821-858.
31. Kim D.J., Lee K.K., Han B.S., Ahn B., Bae J.H., Jang J.J. Biphasic modifying effect of indole-3-carbinol on diethylnitrosamine-induced preneoplastic glutathione S-transferase placental form-positive liver cell foci in Sprague-Dawley rats. Jpn. J. Cancer Res. 85:1994;578-583.
32. Kim D.J., Han B.S., Ahn B., Hasegawa R., Shirai T., Ito N., Tsuda N. Enhancement by indole-3-carbinol of liver and thyroid gland neoplastic development in a rat medium-term multi-organ carcinogenesis model. Carcinogenesis. 18:1997;377-381.
33. Wargovich M.J., Chen C.-D., Jimenez A., Steele V.E., Velasco M., Stephens L.C., Price R., Gray K., Kelloff G.J. Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat. Cancer Epidemiol. Biomarkers Prev. 5:1996;355-360.
34. Kim D.J., Lee K.K., Bae J.H., Jang J.J., Tatematsu M., Furihata C. The inhibitory effects of allyl sulfide and indole-3-carbinol on N-methyl-N′-nitro-N-nitrosoguanidine-induced glandular stomach carcinogenesis in rats. J. Korean Cancer Assoc. 26:1994;392-398.
35. Bradlow H.L., Sepkovic D.W., Telang N.T., Osborne M.P. Indole-3-carbinol: a novel approach to breast cancer prevention. Ann. N. Y. Acad. Sci. 768:1995;180-200.
36. Dashwood R.H. Indole-3-carbinol: anti-carcinogen or tumor promoter in Brassica vegetables? Chem. Biol. Interact. 110:1998;1-5.
37. Manson M.M., Gescher A., Hudson E.A., Plummer S.M., Squires M.S., Prigent S.A. Blocking and suppressing mechanisms of chemoprevention by dietary constituents. Toxicol. Lett. 112-113:2000;499-505.
38. 1-initiated hepatocarcinogenesis: results from a 9000 animal tumor study. Carcinogenesis. 20:1999;453-458.
39. Fukutake M., Nakatsugi S., Isoi T., Takahashi M., Ohta T., Mamiya S., Taniguchi Y., Sato H., Fukuda K., Sugimura T., Wakabayashi K. Suppressive effects of nimesulide, a selective inhibitor of cyclooxygenase-2, on azoxymethane-induced colon carcinogenesis in mice. Carcinogenesis. 19:1998;1939-1942.
40. 1 and cyclin-dependent kinase-4 in azoxymethane-induced mouse colon tumorigenesis. Carcinogenesis. 19:1998;2001-2006.
41. Bird R.P., Good C.K. The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer. Toxicol. Lett. 112-113:2000;395-402.
42. Fennoglio-Preiser C.M., Noffsinger A. Aberrant crypt foci: a review. Toxicol. Pathol. 27:1999;632-642.
43. Kim D.J., Takasuka N., Kim J.M., Sekine K., Ota T., Asamoto M., Murakoshi M., Nishino H., Nir Z., Tsuda H. Chemoprevention by lycopene of mouse lung neoplasia after combined initiation treatment with DEN, MNU, and DMH. Cancer Lett. 120:1997;15-22.
44. Reddy B.S., Rao C.V., Seibert K. Evaluation of a cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res. 56:1996;4566-4569.
45. Labayle D., Fischer D., Vielh P., Drouhin F., Parienc A., Bories C., Duhamel O., Trousset M., Adali P. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology. 101:1991;635-639.
46. Prescott S.M., White R.L. Self promotion? Intimate connections between APC and prostaglandin H synthase-2. Cell. 87:1996;783-786.
47. Shoemaker A.R., Gould K.A., Luongo C., Moser A.R., Dove W.F. Studies of neoplasia in the Min mouse. Biochem. Biophys. Acta. 1332:1997;F25-F48.
48. Oshima M., Oshima H., Kitagawa K., Kobayashi M., Itakura C., Taketo M. Loss of APC heterozygocity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated APC gene. Proc. Natl. Acad. Sci. U.S.A. 92:1995;4482-4486.
49. Rao C.V., Kawamori T., Mamid R., Reddy B.S. Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor. Carcinogenesis. 20:1999;641-644.
50. Willoughby D.A., Moore A.R., Colville-Nash P.R. COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory disease. Lancet. 355:2000;646-648.